Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Targeted Therapies introduces Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Browse by Series:
Case 1: Choosing the Right Therapy for Standard-Risk Myeloma
Case 1: Choosing the Right Therapy for Standard-Risk Myeloma
Case 1: Treatment-Associated Toxicities in Myeloma
Case 1: Treatment-Associated Toxicities in Myeloma
Case 4: 67-Year-Old Woman With Intrahepatic Cholangiocarcinoma
Case 4: 67-Year-Old Woman With Intrahepatic Cholangiocarcinoma
Case 4: Next-Generation Sequencing
Case 4: Next-Generation Sequencing
Case 4: Side Effects of FGFR2 Inhibitors in HCC
Case 4: Side Effects of FGFR2 Inhibitors in HCC
Case 4: QoL Improvement With Treatment of CCA
Case 4: QoL Improvement With Treatment of CCA
Case 4: MUC With Non-Muscle Invasive Recurrence
Case 4: MUC With Non-Muscle Invasive Recurrence
Case 4: Multiple Lines of Therapy in Recurrent Bladder Cancer
Case 4: Multiple Lines of Therapy in Recurrent Bladder Cancer
Case 4: Considering Special Populations in Bladder Cancer
Case 4: Considering Special Populations in Bladder Cancer
Additional Insights: FGFRi-Associated Ocular AEs in Bladder Cancer
Additional Insights: FGFRi-Associated Ocular AEs in Bladder Cancer
Additional Insights: Collaborative Approach to Bladder Cancer
Additional Insights: Collaborative Approach to Bladder Cancer
Additional Insights: Experience with FGFR Inhibitors in Bladder Cancer
Additional Insights: Experience with FGFR Inhibitors in Bladder Cancer
<< Prev Page
Next Page >>
Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.